| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |